9/15/2023IQVIA: Review of Chinese PD-L1 Drug Market in H1/2023

9/15/2023Drug R&D and Product Registration News Digest 09/2023 (2)

9/15/2023Cure Genetics, Frametact to Develop Brain Disease Gene Therapies in $6...

9/15/2023JW Therapeutics and 2Seventy Bio Announce Strategic Partnership to Acc...

9/14/2023China to Manage Monkeypox as Category B Infectious Disease as Covid-19

9/14/2023U.S.-China Track II Dialogue on Healthcare - July 2023 Consensus

9/13/2023Are China's Healthcare and Biopharma Sectors Really Open for Investmen...

9/13/2023Exelixis and Insilico Enter Global Licensing Pact for Anticancer Candi...

9/13/2023AriBio, Shanghai Pharma to Commercialize Oral Alzheimer's Drug AR1001

9/13/2023Clover Biopharma Launches Quadrivalent Influenza Vaccine in Mainland C...

9/13/2023LIB Thera and Hasten Biopharma Announce $325M Strategic Collaboration ...

9/13/2023NHSA Issues the Notice on Further Advancing the Intelligent Review and...

9/12/2023China Adjusts the Catalog of Narcotic and Psychotropic Drugs

9/12/2023CDE Solicits Comments on the Technical Guidelines for Clinical Study o...

9/12/2023CDE Solicits Comments on the Technical Guidelines for Clinical Study o...

9/12/2023Chinese Pharma Companies Expand Foothold in Africa

9/8/2023Recent Official and Executive Moves

9/8/2023Drug R&D and Product Registration News Digest 09/2023 (1)

9/8/2023Ageing Hong Kong Can Be the Greater Bay Area's Pensions and Healthcare...

9/7/2023CDE Releases the Annual Report on New Drug Registration Clinical Trial...

9/7/2023MSD Plans to Boost New Product Launch and Pharma R&D in China

9/6/2023NMPA Solicits Comments on the Guidelines for the Inspection of Third-P...

9/6/2023Pfizer Faces Whistleblower Lawsuit over Alleged FCPA Violations in Chi...

9/5/2023NMPA Issues the Announcement for Applicability of ICH Guidelines S12

9/5/2023NMPA Issues Announcement for Applicability of ICH Guidelines Q9(R1)

9/4/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...

9/1/2023SAMR Solicits Public Comments on the Proposed Compliance Guidelines fo...

9/1/2023CDE Solicits Comments on the Technical Guidelines for Post-Marketing P...

9/1/2023NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...

9/1/2023Recent Executive Moves

Page:90/775 Total number of articles:23233: [First][<<] [88] [89] [90] [91] [92] [>>] [End]